Fundraising FoxEloxxpharma
1 known investors
Find your way into Eloxxpharma
Sign up to see every warm intro you have to Eloxxpharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eloxxpharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics designed to address nonsense mutation genetic disorders. The company is advancing exaluren for rare kidney diseases including Alport syndrome and ADPKD through clinical trials.
Founders & leadership
SA
Sumit AggarwalPresident and Chief Executive OfficerSumit Aggarwal is President and CEO of Eloxx Pharmaceuticals, a clinical-stage biopharmaceutical company. He previously worked in healthcare investing at Adage Capital and management consulting at McKinsey, and held leadership roles at Zikani Therapeutics and Progenity; he holds an engineering degree from IIT Kharagpur and an MBA from Cornell.
Investors · 1
Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya
How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Founder mafia
2 people who came through Eloxxpharma went on to found or lead other companies.
Frequently asked questions
- What does Eloxxpharma do?
- Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics designed to address nonsense mutation genetic disorders. The company is advancing exaluren for rare kidney diseases including Alport syndrome and ADPKD through clinical trials.
- Who are Eloxxpharma's investors?
- Eloxxpharma's investors include Pontifax Venture Capital.